Published in Emerg Infect Dis on May 01, 2007
National survey for Salmonella in pigs, cattle and sheep at slaughter in Great Britain (1999-2000). J Appl Microbiol (2004) 1.41
Traveller's diarrhoea. Lancet Infect Dis (2005) 1.32
Serotypes of salmonella at Ibadan, Nigeria, with special note of the new serotypes isolated in Nigeria. J Infect Dis (1960) 1.04
Nontyphoidal salmonellae in United Kingdom badgers: prevalence and spatial distribution. Appl Environ Microbiol (2003) 0.92
Salmonellae in the African great cane rat (Thryonomys swinderianus). J Wildl Dis (1990) 0.91
[A case of salmonellosis due to "S. agama"]. Arch Fr Pediatr (1966) 0.88
The agama lizard as reservoir of Salmonellae in Nigeria. Nature (1957) 0.84
Isolation of Salmonella from poultry droppings and other environmental sources in Awka, Nigeria. Int J Infect Dis (2005) 0.84
Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol (2006) 3.18
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis (2005) 2.58
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut (2012) 2.49
Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight. Am J Trop Med Hyg (2006) 1.88
Transcriptional profiling of Helicobacter pylori Fur- and iron-regulated gene expression. Microbiology (2005) 1.85
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. J Infect Dis (2008) 1.70
The Helicobacter pylori homologue of the ferric uptake regulator is involved in acid resistance. Infect Immun (2002) 1.65
Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa. Microbes Infect (2005) 1.63
Management of imported malaria in Europe. Malar J (2012) 1.60
Increased prevalence of intestinal helminth infection during pregnancy in a Sub-Saharan African community. Wien Klin Wochenschr (2007) 1.58
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One (2011) 1.45
Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect Immun (2002) 1.43
Adolescence as risk factor for adverse pregnancy outcome in Central Africa--a cross-sectional study. PLoS One (2010) 1.43
Iron-responsive regulation of the Helicobacter pylori iron-cofactored superoxide dismutase SodB is mediated by Fur. J Bacteriol (2005) 1.40
NikR mediates nickel-responsive transcriptional induction of urease expression in Helicobacter pylori. Infect Immun (2002) 1.37
Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria. J Infect Dis (2004) 1.34
Differential regulation of amidase- and formamidase-mediated ammonia production by the Helicobacter pylori fur repressor. J Biol Chem (2002) 1.33
The novel Helicobacter pylori CznABC metal efflux pump is required for cadmium, zinc, and nickel resistance, urease modulation, and gastric colonization. Infect Immun (2006) 1.31
The role of the Ferric Uptake Regulator (Fur) in regulation of Helicobacter pylori iron uptake. Helicobacter (2002) 1.29
Helicobacter pylori multiplex serology. Helicobacter (2009) 1.29
Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol (2002) 1.22
Epidemiology of parasitic co-infections during pregnancy in Lambaréné, Gabon. Trop Med Int Health (2010) 1.20
The Helicobacter pylori CrdRS two-component regulation system (HP1364/HP1365) is required for copper-mediated induction of the copper resistance determinant CrdA. J Bacteriol (2005) 1.20
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial. Infect Immun (2005) 1.17
A novel system of cytoskeletal elements in the human pathogen Helicobacter pylori. PLoS Pathog (2009) 1.15
In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays. Malar J (2009) 1.14
Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon. J Antimicrob Chemother (2007) 1.12
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother (2007) 1.12
Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis. Lancet Infect Dis (2010) 1.10
Magnesium uptake by CorA is essential for viability of the gastric pathogen Helicobacter pylori. Infect Immun (2002) 1.10
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial. Malar J (2012) 1.08
Helicobacter pylori and gastroduodenal ulcer disease. Dtsch Arztebl Int (2009) 1.07
Recent developments in Campylobacter pathogenesis. Curr Opin Infect Dis (2003) 1.07
Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother (2006) 1.07
Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambaréné, Gabon. Am J Trop Med Hyg (2005) 1.01
Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial. Clin Infect Dis (2012) 1.00
Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother (2005) 0.99
Extense variant gene family repertoire overlap in Western Amazon Plasmodium falciparum isolates. Mol Biochem Parasitol (2006) 0.97
Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany. J Antimicrob Chemother (2009) 0.97
Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am J Cardiol (2004) 0.96
Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single- versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection. Antimicrob Agents Chemother (2014) 0.96
New imaging approaches for improving diagnosis of childhood tuberculosis. S Afr Med J (2014) 0.95
Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis. Dig Dis Sci (2003) 0.95
Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review. Malar J (2014) 0.95
Intra-cystic drug concentration of albendazole sulphoxide in patients with Echinococcus granulosus cysts. Am J Trop Med Hyg (2009) 0.94
Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon. Malar J (2012) 0.93
Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro. Int J Parasitol (2006) 0.93
Identification by RNA profiling and mutational analysis of the novel copper resistance determinants CrdA (HP1326), CrdB (HP1327), and CzcB (HP1328) in Helicobacter pylori. J Bacteriol (2002) 0.93
Pathogenesis of Helicobacter pylori infection. Helicobacter (2004) 0.93
Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura. Vaccine (2012) 0.92
Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection. Malar J (2011) 0.91
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis. Malar J (2015) 0.91
Pyronaridine-artesunate combination therapy for the treatment of malaria. Curr Opin Infect Dis (2011) 0.90
Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. Malar J (2010) 0.90
Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals. PLoS One (2012) 0.90
Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach. J Clin Microbiol (2004) 0.90
ABO blood group and the risk of placental malaria in sub-Saharan Africa. Malar J (2011) 0.88
Analysis of the rdxA gene in high-level metronidazole-resistant clinical isolates confirms a limited use of rdxA mutations as a marker for prediction of metronidazole resistance in Helicobacter pylori. FEMS Immunol Med Microbiol (2003) 0.87
Novel plasmids for gene expression analysis and for genetic manipulation in the gastric pathogen Helicobacter pylori. FEMS Immunol Med Microbiol (2005) 0.87
Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori. Antimicrob Agents Chemother (2005) 0.85
Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study. Malar J (2012) 0.85
Culture of a gastric non-Helicobacter pylori Helicobacter from the stomach of a 14-year-old girl. Helicobacter (2012) 0.85
Mutational analysis of the Helicobacter pylori carbonic anhydrases. FEMS Immunol Med Microbiol (2005) 0.85
Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon. Wien Klin Wochenschr (2010) 0.85
Current status of the clinical development and implementation of paediatric artemisinin combination therapies in Sub-Saharan Africa. Wien Klin Wochenschr (2011) 0.83
Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin. BMC Res Notes (2012) 0.83
T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis). Eur Cytokine Netw (2003) 0.83
Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections. Antimicrob Agents Chemother (2012) 0.83
High secondary resistance to quinolones in German Helicobacter pylori clinical isolates. J Antimicrob Chemother (2013) 0.82
Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J Antimicrob Chemother (2007) 0.81
Neural cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum-infected erythrocytes capable of aggregation. Infect Immun (2007) 0.80
Rapid diagnostic algorithms as a screening tool for tuberculosis: an assessor blinded cross-sectional study. PLoS One (2012) 0.80
Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. Int J Antimicrob Agents (2007) 0.80
Helicobacter pylori: primary antimicrobial resistance and first-line treatment strategies. Euro Surveill (2007) 0.78
The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel. Malar J (2011) 0.78
A novel noninvasive genotyping method of Helicobacter pylori using stool specimens. Gastroenterology (2008) 0.78
Treatment of malaria in Austria: hazardous for patients or physicians? Wien Klin Wochenschr (2009) 0.77
Pyronaridine: a new 'old' drug on the verge of entering the antimalarial armamentarium. Expert Rev Anti Infect Ther (2011) 0.77
Molecular microbiology and pathogenesis of Helicobacter and Campylobacter updated: a meeting report of the 11th conference on Campylobacter, Helicobacter and related organisms. Mol Microbiol (2002) 0.77
Isolation and eradication of a clinical isolate of Helicobacter pylori resistant to five antimicrobials in Germany. J Antimicrob Chemother (2010) 0.77
Current evidence and future of automated erythrocyte exchange in the treatment of severe malaria. Wien Klin Wochenschr (2012) 0.77
Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide-induced gastric ulcer in rats. J Pharm Pharmacol (2008) 0.77
[Differences of vacA alleles and cagA gene positivity of Helicobacter pylori strains isolated from two different countries: Turkey and Germany]. Mikrobiyol Bul (2012) 0.76
Adherence of patients to long-term medication: a cross-sectional study of antihypertensive regimens in Austria. Wien Klin Wochenschr (2015) 0.76
Anaplasmataceae-Specific PCR for Diagnosis and Therapeutic Guidance for Symptomatic Neoehrlichiosis in Immunocompetent Host. Emerg Infect Dis (2016) 0.75
Loa loa Infection in Pregnant Women, Gabon. Emerg Infect Dis (2015) 0.75
Re: the impact of the stone age diet on gingival conditions in the absence of oral hygiene. Baumgartner S, Imfeld T, Schicht O, Rath C, Persson RE, Persson GR. (J Periodontol 2009;80:759-768.). J Periodontol (2010) 0.75
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria. Emerg Infect Dis (2016) 0.75
Emergence of a Helicobacter pylori isolate with reduced susceptibility to tetracycline in Germany. J Antimicrob Chemother (2006) 0.75
Treatment of childhood tuberculosis: caregivers' practices and perceptions in Cape Town, South Africa. Paediatr Int Child Health (2014) 0.75